🇺🇸

US SEC Filing Intelligence

· daily

Federal IT & Cybersecurity Contracts — August 21, 2026

This digest covers two civilian agency IT contracts totaling $813M, with zero defense exposure, signaling robust non-DOD federal IT spending. The dominant theme is GSA and NIH IT modernization, led by a $674M CACI cost-plus award from GSA that provides low-risk, predictable revenue but carries an unusual negative outlay requiring monitoring. A $139M NIH cloud services contract to HIGHRISE CONSULTING shows strong execution with 65% already outlayed, indicating low cancellation risk. The highest-conviction signal is CACI's competitive win on technical merit, though the contract's 2019 start and 2024 end date raise re-compete risk. Key watch items include clarifying CACI's negative outlay and tracking HIGHRISE's ability to secure follow-on task orders.

2 total filings
· daily

All HHS Contracts — August 21, 2026

The two HHS contracts totaling $402.2 million reveal a civilian-agency focus with a strong biodefense and IT modernization theme. The largest award, a $263.6 million BARDA contract to the nonprofit Sabin Vaccine Institute for Marburg virus R&D, signals sustained government investment in pandemic preparedness but offers no direct equity exposure. The second award, a $138.6 million NIH IT services delivery order to Highrise Consulting, shows stable recurring revenue from cloud support with 65% already outlayed, reducing cancellation risk. Key risks include the long performance period (10 years) for the Sabin contract and potential budget uncertainty under a continuing resolution. The highest-conviction signal is the high utilization rate on the Highrise contract, indicating strong execution and low termination risk.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — August 21, 2026

This digest covers $1.60B in obligations across five contracts from August 21, 2026, with only one defense-related award (20% defense/civilian split), signaling a heavy tilt toward civilian agency IT and biodefense spending. The highest-conviction signal is CACI’s $674M GSA IT services win, a bullish, low-risk cost-plus contract that reinforces its federal IT moat, though the negative net outlay (-$415K) warrants monitoring. The dominant theme is civilian IT modernization (CACI, HIGHRISE) and biodefense R&D (Sabin Vaccine Institute), with NASA’s Teledyne Brown contract already expired, offering zero future revenue. Key risk: the $263.6M Sabin contract is with a non-profit, limiting direct equity exposure, while HSGS-AMERESCO’s $149M VA ESPC carries high fixed-price execution risk.

5 total filings
· daily

High-Value Federal Grants ($5M+) — August 21, 2026

This digest covers $1.6 billion in federal obligations across five contracts, with only one defense-related award (20% defense mix), signaling a civilian-heavy procurement period led by GSA, NASA, HHS, and VA. The highest-conviction signal is CACI's $674M GSA IT services contract, which offers low-risk cost-plus revenue through 2024 but carries a negative net outlay anomaly requiring monitoring. Key risks include Teledyne Brown Engineering's NASA contract ending in 2022 with no follow-on visibility, and HSGS-AMERESCO's fixed-price VA energy contract exposing it to performance risk. The dominant theme is civilian IT and biodefense spending, with limited direct defense exposure.

5 total filings
· daily

General Federal Contracts — August 21, 2026

This digest covers five contracts totaling $1.597 billion, with only one defense-related award (20% of records) and the remainder civilian, primarily from HHS and NASA. The dominant theme is stable, multi-year IT and biodefense spending, with CACI's $674M GSA IT services contract as the highest-conviction signal, offering predictable cost-plus revenue through 2024. Key risks include the expired Teledyne Brown NASA contract ($371.5M) with no follow-on visibility and the nonprofit Sabin Vaccine Institute award ($263.6M) limiting direct equity exposure. Investors should monitor CACI's contract execution and potential recompete, as well as BARDA's option exercises for biodefense funding continuity.

5 total filings
· daily

All NASA Contracts — August 21, 2026

This digest analyzes a single NASA contract awarded to Teledyne Brown Engineering, a subsidiary of Teledyne Technologies, valued at $371.5M for ISS mission operations support. The contract is entirely civilian (0% defense-related) and has already ended (December 2022), making it a historical data point rather than a current revenue driver. The highest-conviction signal is the significant gap between the obligated value ($371.5M) and actual outlays ($151.3M), suggesting the contract underperformed relative to its ceiling. The key risk is that this contract represents a past revenue stream with no current contribution, and investors should watch for any follow-on awards to gauge Teledyne's retained position in NASA's manned spaceflight operations.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 21, 2026

The 10 filings from the S&P 500 Technology sector on August 21, 2026, reveal a pronounced insider selling pattern among top executives at major cybersecurity and semiconductor firms, including CrowdStrike, Datadog, and AMD, all executed under Rule 10b5-1 plans, which may indicate pre-planned portfolio diversification rather than immediate bearish conviction. Palo Alto Networks' bylaw amendments signal a defensive governance posture ahead of the next annual meeting cycle, potentially to deter activist or shareholder proposals. AppLovin saw multiple C-suite insiders (CEO, CFO, CTO, CLO, Director) engage in tax-withholding share surrenders, a routine but notable cash-out event at a $308.77 price point. No period-over-period financial trends, forward-looking guidance, or capital allocation changes were disclosed in these filings, limiting the ability to derive growth or margin trends. The lack of earnings or operational updates across all filings suggests a quiet period post-earnings season, with insider activity being the primary actionable signal. The concentrated insider selling across high-profile tech names warrants close monitoring for any subsequent negative guidance or sector headwinds.

10 high priority 10 total filings
· daily

Nasdaq 100 Stocks SEC Filings — August 21, 2026

The 17 filings from NASDAQ-100 constituents for August 21, 2026, are dominated by insider transactions, revealing a clear pattern of management monetization across several key holdings. The most significant cluster is at **CoreWeave (CRWV)**, where seven top executives (including the CEO, CFO, COO, and CSO) collectively sold over $4.8 million in Class A Common Stock at $91.88, representing a coordinated and material insider liquidation event. This is the most critical development, signaling potential concern about the company's near-term valuation or business trajectory. In contrast, **AppLovin (APP)** shows a non-selling pattern, with four insiders (CEO, CLO, Director, CFO, CTO) only having shares withheld for taxes, indicating no discretionary selling. **Advanced Micro Devices (AMD)** saw its CTO sell $4.52M under a 10b5-1 plan, while **QUALCOMM (QCOM)** and **Gilead Sciences (GILD)** had smaller, planned sales by senior officers. The overall portfolio-level theme is one of insider caution, particularly in the AI-infrastructure and semiconductor sectors, with no bullish insider buying detected across any of the 17 filings. No period-over-period financial comparisons, forward-looking guidance, or capital allocation changes were present in these filings, limiting trend analysis to insider behavior patterns.

17 high priority 17 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 21, 2026

This digest of 38 SEC filings reveals a period of significant portfolio restructuring and capital reallocation. The most dominant theme is the unwinding of large, long-held positions, highlighted by Liberty Broadband's complete exit from both Charter Communications and comScore following its acquisition by Charter, and the disbanding of the Brera Holdings group. Concurrently, we see aggressive accumulation by activist-leaning funds, particularly Steamboat Capital's rapid build of a 7.1% stake in Medifast and Hyperscale Data's continued buying in Universal Safety Products. A notable pattern of 'passive conversion' is emerging, where entities like Tang Capital and White River Ventures are switching from activist (13D) to passive (13G) filings, signaling a de-escalation of control intentions. Insider activity is mixed; while CEO Eric Singer of Immersion Corp has a large personal stake, the complete exit by Westerly Capital from Harte Hanks and Almitas Capital from multiple positions suggests a lack of conviction in certain names. The data points to a market where sophisticated capital is rotating out of legacy positions and into specific, high-conviction bets, creating both risks and opportunities for investors.

20 high priority 18 medium 38 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 21, 2026

The four filings from the S&P 500 Financials sector reveal a notable pattern of insider selling by key stakeholders, including a CFO at Intercontinental Exchange (ICE) and major 10% owners at Robinhood Ventures Fund I and AFLAC. All three insider transactions were executed under Rule 10b5-1 plans, suggesting pre-planned, non-discretionary sales, which somewhat mitigates the bearish signal but still indicates a lack of incremental buying conviction. The ICE 8-K filing is a routine, low-materiality credit agreement amendment, reflecting standard corporate housekeeping. No period-over-period comparisons, forward-looking guidance, or capital allocation changes were present in any of the filings, limiting the depth of trend analysis. The overarching theme is a cautious, neutral-to-negative insider sentiment across the subsectors of exchanges, fintech, and insurance, with no bullish catalysts emerging from the data.

4 high priority 4 total filings
· daily

S&P 500 Energy Sector SEC Filings — August 21, 2026

The S&P 500 Energy sector shows a mixed picture with insider selling at ConocoPhillips signaling potential caution, offset by a small insider buy at Texas Pacific Land Corp. The sector is characterized by routine corporate governance and financing activities, with Williams Companies seeing a board retirement and Phillips 66 executing a routine refinancing. No significant period-over-period trends or forward-looking guidance changes were identified across the filings. The most notable development is the insider sale by ConocoPhillips' SVP & General Counsel, which, while not massive in context, warrants monitoring for further insider activity. The sector appears stable but with limited near-term catalysts from these filings.

4 high priority 4 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 21, 2026

The six filings for the S&P 500 Consumer Staples stream reveal a clear divergence in insider behavior: top executives at Walmart and Coca-Cola are executing significant, pre-planned stock sales, signaling potential near-term caution or portfolio diversification, while Procter & Gamble is issuing large equity awards to its leadership team, indicating a focus on long-term retention and alignment. The period-over-period data from the enriched filings shows no direct revenue or margin trends, but the insider activity pattern is notable—two major consumer staples companies saw insider sales totaling over $4.8 million, which could be a sector-level signal of perceived overvaluation or a need for liquidity. In contrast, P&G's awards to four top executives, including the CFO and business unit CEOs, suggest confidence in future performance and a desire to lock in key talent. The lack of forward-looking guidance or capital allocation changes in these filings limits the catalyst calendar, but the insider trading data provides actionable intelligence for investors to monitor. Overall, the sector appears stable but with pockets of insider caution that warrant attention, especially given the high materiality of the Coca-Cola sale.

6 high priority 6 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 21, 2026

The 19 filings from S&P 500 Industrials constituents reveal a sector bifurcated between steady organic growth and rising cost pressures. Parker-Hannifin (PH) dominates the filing set with 12 insider equity awards and a comprehensive 10-K showing 8.3% revenue growth to $21.5B, but a sharp 600 bps increase in its effective tax rate (to 20.0%) and a swing to a $330M loss in other expense/income, compressing net income growth to just 3.3%. Northrop Grumman (NOC) issued a unique stock-price-linked retention grant to its CEO, signaling board focus on shareholder alignment. Illinois Tool Works (ITW) saw a director exercise and sell a combined ~$14M in stock, a notable insider liquidation. Boeing (BA) announced a routine but material C-suite succession. The dominant theme is capital allocation toward long-term incentive compensation (SARs and MSUs) across PH and NOC, while ITW's insider selling and PH's tax/income headwinds warrant caution. The portfolio shows no uniform margin trend, but PH's data points to a potential earnings quality concern from one-time items.

19 high priority 19 total filings
· daily

US Material Events SEC 8-K Filings — August 21, 2026

The August 21, 2026, filing cycle reveals a market bifurcated between aggressive capital-raising and strategic restructuring. A significant cluster of companies, including Applied Optoelectronics ($600M ATM), OS Therapies ($75M ATM), and Enova International ($301M securitization), are actively tapping equity and debt markets, signaling a high demand for growth or working capital. This is counterbalanced by a wave of corporate failures and restructurings, such as the termination of the BSTR/Cantor Equity Partners merger, the failed Mangoceuticals/Nuclea Energy deal, and the strategic review at NEXGEL. Insider activity is notably absent, with no major insider buying or selling detected across the 50 filings, suggesting a cautious or neutral stance from management. The most actionable themes are the refinancing of high-cost debt (Gray Media saving ~300 bps on $675M) and the emergence of distressed financing situations (Edgemode, Nexalin) that signal severe financial strain. The overall tone is one of strategic repositioning, with companies either fortifying balance sheets or facing existential challenges.

50 high priority 50 total filings
· daily

Insider Trading Pulse — August 21, 2026

Today's insider trading digest reveals a clear divergence between aggressive insider buying at deeply discounted valuations and significant, often 10b5-1 plan-driven, selling by top executives at growth and technology companies. The most notable buying signals emanate from 51Talk Online Education Group (CEO bought $3.19M), Prothena Corp (10% owner bought $439K), and Alico (director bought $50K), suggesting strong conviction in turnaround or value stories. Conversely, a wave of selling hit Sea Ltd (4 executives sold, including COO for $1.08M), Freshpet (CEO sold $3.07M), and Twist Bioscience (exec sold $1.84M), though much of this is pre-planned. A cluster of insider purchases at Lument Finance Trust (CEO and director bought $25K combined) and High Income Securities Fund (director bought $134K) points to value-seeking in financials and closed-end funds. The overall picture is one of cautious optimism in select value plays, while growth names see continued executive profit-taking. No material period-over-period comparisons or forward-looking guidance changes were available in the filings to alter this narrative.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 21, 2026

A massive wave of 16 8-K filings on a single day (August 21, 2026) reveals an acute corporate distress event across the US public markets, primarily concentrated in the healthcare and technology sectors. A staggering 15 of the 16 filings are from companies receiving Nasdaq deficiency or delisting notices, with materiality ratings of 8/10 or 9/10 in nearly every case. The three primary distress triggers are: (1) failure to maintain the minimum $1.00 bid price (5 companies: VivoSim Labs, Citius, BioCardia, Pasithea, Estrella), (2) failure to meet the minimum $2.5 million stockholders' equity requirement (4 companies: Silexion, TruGolf, Dragonfly Energy, Adial), and (3) failure to timely file periodic reports (3 companies: Global Interactive, SolarMax, Synergy CHC). The most severe cases involve Silexion Therapeutics and Rain Enhancement Technologies, which have already received delisting notices with imminent hearing deadlines; their shareholders' equity of only $44,000 and failure to cure market value deficiencies, respectively, place them in the highest risk category. This concentration highlights systemic weakness in micro-cap and pre-revenue biotech/life sciences companies that have been unable to access follow-on capital in a challenging market environment. There is no benign explanation for this cluster; it is a fundamental capital structure crisis.

16 high priority 16 total filings
· daily

Global High-Priority Regulatory Events — August 21, 2026

This digest covers 50 filings from August 21, 2026, revealing a market bifurcated between aggressive corporate restructuring and a wave of micro-cap distress. The most critical theme is a deluge of Nasdaq non-compliance notices, with 14 companies receiving deficiency warnings for low bid prices, insufficient equity, or delinquent filings, signaling a potential wave of micro-cap delistings. Concurrently, there is significant M&A and restructuring activity, including a $180M SPAC merger for Everli Global, a major insolvency admission for Satiate Agri Ltd (₹6.27 Cr default), and the final deregistration of QVC Group post-bankruptcy. Insider activity was limited, but a notable promoter acquisition in Orissa Bengal Carrier and a related-party acquisition by KPI Green Energy highlight specific capital allocation moves. The overarching theme is one of cleansing: distressed micro-caps face existential threats while larger entities pursue strategic consolidation and new ventures, creating a high-risk, high-opportunity environment for event-driven investors.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 21, 2026

Today's filings reveal a market bifurcated between aggressive corporate restructuring and operational stress. The most significant themes are a wave of M&A activity facing execution hurdles (LivePerson, BSTR Holdings, Simulations Plus) and a sharp deterioration in credit quality at smaller financials (GBank Financial). On the positive side, several companies are executing strategic refinancings (Methanex, Jefferson Capital) and capital allocation shifts (News Corp buyback). Insider selling at Sea Ltd by multiple C-suite executives under 10b5-1 plans is a notable bearish signal for the tech sector. The data shows a clear pattern of revenue growth being offset by margin compression and rising interest costs across industrials and consumer-facing companies (Sysco, Dingdong). The upcoming week is catalyst-heavy with key shareholder votes on transformative M&A (LivePerson, Pasqal, Simulations Plus) that will determine the fate of several high-profile deals.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 21, 2026

The five filings from the S&P 500 Consumer Discretionary sector for August 21, 2026, center exclusively on Home Depot and Yum! Brands, revealing a period of executive restructuring and insider capital movements rather than broad operational or financial updates. Home Depot dominates the filing activity with a series of insider transactions and an 8-K detailing expanded roles for three senior executives, each receiving $500,000 in restricted stock awards. The most critical development is the CFO's sale of $2.09 million in stock following an option exercise, which, while potentially part of routine tax planning, introduces a bearish signal given his oversight of the company's strategic 'Pro Acceleration' office. Yum! Brands' appointment of a new director is a low-materiality governance event. No period-over-period financial comparisons or forward-looking guidance were provided in any filing, limiting the ability to derive revenue or margin trends. The overall portfolio-level pattern is one of management realignment and insider activity, with no cross-cutting sector themes emerging from the limited data set.

5 high priority 5 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 21, 2026

The two S&P 500 Healthcare filings today reveal a pattern of insider selling, albeit at low materiality levels, suggesting routine portfolio management rather than acute bearish sentiment. Gilead Sciences shows a director executing a 10b5-1 plan with a net sale of ~$167K after exercising options, indicating pre-planned diversification. Intuitive Surgical's EVP sold a minimal ~$30.5K worth of stock, also under a 10b5-1 plan, reflecting standard compliance selling. No period-over-period trends, forward guidance, capital allocation changes, or M&A activity were present in these filings, limiting the depth of cross-company synthesis. The sector theme is muted insider activity with no red flags, but the lack of bullish signals (e.g., insider buying, guidance raises) keeps the overall tone neutral. Investors should monitor upcoming earnings calls and any shifts in insider behavior for clearer directional cues.

2 high priority 2 total filings